Vivo Capital, LLC Diversified Active

Location: Palo Alto, CA

CIK: 0001674712 · Show all filings

Period: Q2 2017 (← Previous) (Next →)

Filing Date: Aug 2, 2017

Total Value: $397M (100.0% shares, 0.0% debt)

Holdings (26)

ACRS Aclaris therapeutics 19.5%

Value $77.52M Shares 2,858,569 Est. Cost $19.11 Unrealized +42.3%

— Biohaven Pharmaceutical Holding Company Ltd 12.4%

Value $49.42M Shares 1,976,818 Est. Cost $25.00 Unrealized —

ASND Ascendis Pharma 12.4%

Value $49.05M Shares 1,766,832 Est. Cost $17.51 Unrealized —

— Nabriva Therapeutics AG 10.6%

Value $42.15M Shares 4,021,559 Est. Cost $8.31 Unrealized —

CDXS Codexis, Inc. 7.3%

Value $28.86M Shares 5,294,825 Est. Cost $3.85 Unrealized +19.3%

— Selecta Biosciences, Inc. 5.6%

Value $22.23M Shares 1,119,189 Est. Cost $19.86 Unrealized —

— Strongbridge Biopharma plc 5.4%

Value $21.45M Shares 3,000,000 Est. Cost $2.40 Unrealized —

— Aimmune Therapeutics, Inc. 4.0%

Value $15.97M Shares 776,813 Est. Cost $10.99 Unrealized —

— Eiger BioPharmaceuticals 3.6%

Value $14.12M Shares 1,787,091 Est. Cost $16.42 Unrealized —

— Advanced Accelerator Applications S.A. 3.5%

Value $14.01M Shares 358,786 Est. Cost $35.30 Unrealized —

— Verona Pharma Plc 2.1%

Value $8.208M Shares 704,225 Est. Cost $11.66 Unrealized —

— Capnia, Inc. 1.9%

Value $7.362M Shares 14,695,264 Est. Cost $0.95 Unrealized —

— BioPharmX Corporation 1.7%

Value $6.752M Shares 14,096,338 Est. Cost $0.38 Unrealized —

AUPH Aurinia Pharmaceuticals Inc. 1.6%

Value $6.211M Shares 1,013,149 Est. Cost $5.48 Unrealized +22.9%

— Agile Therapeutics, Inc. 1.4%

Value $5.677M Shares 1,513,975 Est. Cost $6.21 Unrealized —

— Trevena, Inc. 1.0%

Value $3.974M Shares 1,728,000 Est. Cost $7.67 Unrealized —

— Foamix Pharmaceuticals Ltd. 1.0%

Value $3.967M Shares 855,000 Est. Cost $9.26 Unrealized —

— Dynavax Technologies Corporation 0.9%

Value $3.472M Shares 359,827 Est. Cost $19.24 Unrealized —

RGNX Regenxbio Inc. 0.8%

Value $3.247M Shares 164,403 Est. Cost $12.80 Unrealized +51.3%

— Sierra Oncology, Inc. 0.7%

Value $2.853M Shares 2,438,270 Est. Cost $1.17 Unrealized —

— Akari Therapeutics Plc 0.6%

Value $2.433M Shares 527,842 Est. Cost $14.00 Unrealized —

CRSP CRISPR Therapeutics AG 0.6%

Value $2.385M Shares 148,878 Est. Cost $18.69 Unrealized -11.6%

— KalVista Pharmaceuticals, Inc. 0.6%

Value $2.21M Shares 300,325 Est. Cost $7.36 Unrealized —

— ReVance Therapeutics, Inc. 0.5%

Value $2.043M Shares 77,373 Est. Cost $24.38 Unrealized —

— Sunesis Pharmaceuticals, Inc. 0.3%

Value $1.35M Shares 500,000 Est. Cost $3.62 Unrealized —

— Capnia, Inc. 0.0%

Value $159K Shares 943,858 Est. Cost $0.23 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
ACRS	Aclaris therapeutics	2,858,569	$77.52M	19.5%	$19.11	+42.3%	Common	00461U105
—	Biohaven Pharmaceutical Holding Company Ltd	1,976,818	$49.42M	12.4%	$25.00	—	Common	0G1196105
ASND	Ascendis Pharma	1,766,832	$49.05M	12.4%	$17.51	—	ADR	04351P101
—	Nabriva Therapeutics AG	4,021,559	$42.15M	10.6%	$8.31	—	ADR	62957M104
CDXS	Codexis, Inc.	5,294,825	$28.86M	7.3%	$3.85	+19.3%	Common	192005106
—	Selecta Biosciences, Inc.	1,119,189	$22.23M	5.6%	$19.86	—	Common	816212104
—	Strongbridge Biopharma plc	3,000,000	$21.45M	5.4%	$2.40	—	Ordinary Shares	G85347105
—	Aimmune Therapeutics, Inc.	776,813	$15.97M	4.0%	$10.99	—	Common	00900T107
—	Eiger BioPharmaceuticals	1,787,091	$14.12M	3.6%	$16.42	—	Common	28249U105
—	Advanced Accelerator Applications S.A.	358,786	$14.01M	3.5%	$35.30	—	Common	00790T100
—	Verona Pharma Plc	704,225	$8.208M	2.1%	$11.66	—	ADS	925050106
—	Capnia, Inc.	14,695,264	$7.362M	1.9%	$0.95	—	Common	14066L105
—	BioPharmX Corporation	14,096,338	$6.752M	1.7%	$0.38	—	Common	09072X101
AUPH	Aurinia Pharmaceuticals Inc.	1,013,149	$6.211M	1.6%	$5.48	+22.9%	Common	05156V102
—	Agile Therapeutics, Inc.	1,513,975	$5.677M	1.4%	$6.21	—	Common	00847L100
—	Trevena, Inc.	1,728,000	$3.974M	1.0%	$7.67	—	Common	89532E109
—	Foamix Pharmaceuticals Ltd.	855,000	$3.967M	1.0%	$9.26	—	Common	M46135105
—	Dynavax Technologies Corporation	359,827	$3.472M	0.9%	$19.24	—	Common	268158201
RGNX	Regenxbio Inc.	164,403	$3.247M	0.8%	$12.80	+51.3%	Common	75901B107
—	Sierra Oncology, Inc.	2,438,270	$2.853M	0.7%	$1.17	—	Common	74346L101
—	Akari Therapeutics Plc	527,842	$2.433M	0.6%	$14.00	—	ADR	00972G108
CRSP	CRISPR Therapeutics AG	148,878	$2.385M	0.6%	$18.69	-11.6%	Common	H17182108
—	KalVista Pharmaceuticals, Inc.	300,325	$2.21M	0.6%	$7.36	—	Common	048349710
—	ReVance Therapeutics, Inc.	77,373	$2.043M	0.5%	$24.38	—	Common	761330109
—	Sunesis Pharmaceuticals, Inc.	500,000	$1.35M	0.3%	$3.62	—	Common	867328700
—	Capnia, Inc.	943,858	$159K	0.0%	$0.23	—	Warrant	14066L113